FDA Issues Warning About Thermography

Article

Thermography not a replacement for mammography

The Food and Drug Administration (FDA) today released a consumer warning that thermography should not be used in place of mammography for breast cancer screening or diagnosis.

The FDA says mammography- an X-ray of the breast-is still the most effective way of detecting breast cancer in its earliest stages.  The wanring does not mention digital mammogrpahy or other modalities. 

While thermography is cleared by FDA for use as an adjunct, or additional tool, it should not be used by itself to screen for, or diagnose, breast cancer, the agency clarifies.

Learn more about the FDA's concerns about the use of thermography as a screening tool at
http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm257499.htm

 

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
Diagnostic Imaging’s Top Five Breast Imaging Content: Summer 2025
Reducing Mammography Workload by Nearly 40 Percent? What a New Hybrid AI Study Reveals
Diagnostic Imaging's Weekly Scan: August 11 — August 17 (Video Version)
© 2025 MJH Life Sciences

All rights reserved.